Elie Dolgin, PHD, Science Journalist
Springer Nature logo

Nature

By Elie Dolgin February 12, 2025
Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with fewer side effects.
Hand holding two blue pills
By Elie Dolgin January 30, 2025
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
Mouse brain tissue imaged using expansion microscopy.
By Elie Dolgin January 13, 2025
How a tissue-swelling method brought super-resolution imaging to the masses.
Woman's face with visor-style sunglasses shining light into her blue eyes.
By Elie Dolgin October 2, 2024
Pulses of light and sound seem to have beneficial effects. But some argue it is too soon to market experimental devices.
Image of brain inside a head
By Elie Dolgin September 26, 2024
The medication is the first in decades to have a different mode of action than do current drugs, achieving better symptom relief with fewer side effects.
By Elie Dolgin June 11, 2024
Moderna employees build RNA vaccines tailored to an individual’s tumour at a facility in Norwood, Massachusetts.
Kids getting an eye exam
By Elie Dolgin May 29, 2024
Time spent outdoors is the best defence against rising rates of short-sightedness, but scientists are searching for other ways to reverse the troubling trend.
mRNA inside a lipid nanoparticle
By Elie Dolgin April 3, 2024
Drug trial results show that vaccines aren't the only use for the mRNA technology behind the most widely used COVID-19 jabs.
Insulin-producing pancreatic islet cells
By Elie Dolgin February 28, 2024
Gene-editing strategies that allow stem cells to evade the immune system offer hope for universal cell-replacement therapies.
Phase separation causes complex mixtures to segregate — like oil droplets in water.
By Elie Dolgin February 27, 2024
Imaging and molecular manipulation reveal how ‘condensates’ form and offer clues to the role of phase separation in health and disease.
Show More
Share by: